Parexel takes ‘significant step forward’ in RWE strategy with Shyft Analytics

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/everythingpossible)
(Image: Getty/everythingpossible)

Related tags: RWE, Parexel, Medidata, Data management, Real world data

Parexel is adopting Medidata’s Shyft Analytics platform to bolster its real-world evidence generation and outcomes research offering to biopharmaceutical and medical device clients.

Shyft Analytics is a Medidata Solutions company, which this week has signed a strategic partnership agreement with Parexel, a global biopharmaceutical services provider.

Michelle Hoiseth, chief data officer, Parexel​, said the new collaboration with Shyft – as well as its recent partnership with Datavant​, which enhances the company’s data-linking capabilities – is a “significant step forward”​ in its approach to help sponsors leverage real-world data.

“The availability of real-world data is growing, however, innovative analytics methods and technology are needed in order gain insights from that data,”​ she told us.

“Leveraging Shyft’s Quantum RWE platform significantly advances our dynamic modeling capability and reduces the time to analyses in our healthcare data-based strategy, design, and modeling.”

With Shyft’s technology, Parexel will be able to perform at-scale analyses, including cohort modeling, trial feasibility assessment, and large-scale observational studies – “research that will have broad impact across the drug development and market access spectrum,”​ said Hoiseth.

According to a study​ commissioned by Parexel and published by the Economist Intelligence Unit (EIU), the likelihood of new product launch increased by 21% for trials using real-world data.

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

Related suppliers

Follow us

Products

View more

Webinars